IPAH

Interpharm Holdings, Inc. IPAH

IPAH
Interpharm Holdings, Inc. PXYN
Praxsyn Corporation DNAG
DNAPrint Genomics, Inc. IMMB
Immunotech Laboratories, Inc. USRM
U.S. Stem Cell, Inc. JNHMF
Jack Nathan Medical Corp. SPPH
Spencer Pharmaceutical Inc. MHTX
Manhattan Scientifics, Inc. REFG
Medical Cannabis Payment Solutions, Inc. INLB
Item 9 Labs Corp.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode IPAH PXYN DNAG IMMB USRM JNHMF SPPH MHTX REFG INLB
6M 0.00 % 0.00 % 0.00 % 0.00 % -50.00 % -75.00 % 0.00 % 0.00 % 0.00 % 0.00 %
YTD 0.00 % 0.00 % 900.00 % 0.00 % 0.00 % -88.89 % 0.00 % -88.89 % 0.00 % 0.00 %
1Y 0.00 % 0.00 % 900.00 % 0.00 % 0.00 % -95.65 % 0.00 % -87.50 % 0.00 % 9 900.00 %
3Y 409 900.00 % 900.00 % 900.00 % -50.00 % -97.92 % -98.39 % 614.29 % -99.00 % -92.86 % -99.95 %
5Y 409 900.00 % -98.00 % -99.00 % 0.00 % -98.63 % -99.86 % 9 900.00 % -99.75 % -99.61 % -100.00 %
10Y 40 900.00 % -99.88 % -99.00 % 0.00 % -99.99 % -99.95 % 9 900.00 % -99.85 % -99.82 % -99.86 %
From the beginning -82.77 % -100.00 % -100.00 % 0.00 % -100.00 % -99.95 % 9 900.00 % -100.00 % -99.96 % -100.00 %

Dividend